WT1 and acute myeloid leukemia: Ujj et al. proposed that disappearance of WT1 positivity during chemotherapy had a favorable effect on survival and no difference was observed between the survivals of WT1-positive subgroups that expressed moderate or high levels of WT1 [11], which means that achieving WT1 negativity is important in the treatment of AML.